Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.
Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.
复制标题
癌症生物标志物发现：靶向糖蛋白的基于凝集素的策略。
DOI：
10.3233/dma-2012-0904
复制
发表时间：
2012
期刊：
影响因子：
--
通讯作者：
Mao L
中科院分区：
文献类型：
--
作者：
Clark D;Mao L
生物标志物发现可以识别各种癌症中的分子标志物，可用于检测、筛查、诊断和监测疾病进展。凝集素亲和力是一种可用于从复杂样品中富集糖蛋白的技术，有助于发现与疾病状态相关的新型癌症生物标志物。
Biomarker discovery can identify molecular markers in various cancers that can be used for detection, screening, diagnosis, and monitoring of disease progression. Lectin-affinity is a technique that can be used for the enrichment of glycoproteins from a complex sample, facilitating the discovery of novel cancer biomarkers associated with a disease state.